PFI‐3, a selective pharmacological antagonist targeting the bromodomain of the SWI/SNF chromatin remodelling complex, disrupts chromatin remodelling and DNA damage repair, thereby inducing cancer cell death through necrosis and senescence. The gene discussed is SMARCA1; the disease is cancer.